# Eurofins Lancaster Laboratories, Inc – FDA Inspection, Oct 6, 2009

Source: https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/28f6d683-eeef-4e09-8a37-3028ff535f1f
Source feed: FDA_Inspections

> FDA inspection 631027 of Eurofins Lancaster Laboratories, Inc, October 06, 2009. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 631027
- Company Name: Eurofins Lancaster Laboratories, Inc
- Inspection Date: 2009-10-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1284580 - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1)
- [FDA Inspection 1279557 - 2025-08-26](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22)
- FDA Inspection 1156933 - 2021-10-21
- FDA Inspection 1113269 - 2019-10-17
- FDA Inspection 1106449 - 2019-09-13

Company: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c